课题基金 / 基金详情

COLLABORATIVE STUDIES OF NEUROENDOCRINE CIRCULATORY CONTROL

COLLABORATIVE STUDIES OF NEUROENDOCRINE CIRCULATORY CONTROL
神经内分泌循环控制的合作研究
批准号:
4694554
负责人:
D S GOLDSTEIN
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

D S GOLDSTEIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have collaborated with several other groups in studies of neuroendocrine control of the circulation. We developed the first primate model for DOCA/salt hypertension. This form of hypertension is not associated with elevated levels of plasma catecholamines, and it is insensitive to adrenergic blockers but sensitive to diuretics. Chronically repeated pressor episodes resulting from operant diastolic blood pressure condditioning only inconsistently produced sustained increases in blood pressure in baboons. We found evidence for functional corticotropin-releasing hormone (CRF) receptors on adrenomedullary and sympathetic ganglionic cells. In human subjects who received ovine CRF, morphine blunted the ACTH response to CRF without affecting plasma catecholamines or vasopressin. In subjects undergoing third molar extractions, larger inreases in plasma epinephrine than norepinephrine (NE) were observed. Increases in immunoreactive beta-endorphin during the surgery were blocked by fentanyl without affected the catecholamine response. Administration of the mycotoxin, T-2, produces circulatory shock, associated with high catecholamine levels, apparently due to lactic acidosis. Intrarenal infusion of atrial natriuretic factor (ANF) did not affect urinary norepinephrine or dopamine production in dogs. ANF appears to inhibit differentially alpha adrenoceptor subtypes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pilot Projects - Autonomic Rare Diseases Clinical Research Consortium
  • 批准号:
    7901216
  • 项目类别:
  • 资助金额:
    $7.8万
  • 财政年份:
    2009
  • 负责人:
    D S GOLDSTEIN
  • 依托单位:
BIOCHEMICAL METHODS FOR VASOACTIVE SUBSTANCES
COLLABORATIVE STUDIES OF NEUROENDOCRINE PHARMACOLOGY AND PHYSIOLOGY
SYMPATHOADRENAL AND CATECHOLAMINERGIC FUNCTION IN HEALTH AND DISEASE
海外基金